Associate Professor Fiona Simpson is a Fellow of the Queensland Head and Neck Cancer Centre. Her lab focuses on the translation of research findings into new cancer therapies and have recently generated an exciting new method for antibody-mediated cancer therapy. This breakthrough method reduces tumour target variation, reversing drug resistance and increasing drug targeting to tumour cells. In this presentation, Fiona will share the findings of her labs recently completed Phase IB safety trials.
Hear more about The Simpson Lab Research Program
Associate Professor Fiona Simpson
Associate Professor Fiona Simpson completed her PhD on cellular trafficking at the University of Cambridge, UK. She was a Welcome Trust Prize Post-doctoral fellow at The Scripps Research Institute, La Jolla, working on trafficking and endocytosis of RTKs. Fiona is currently a Fellow of the Queensland Head and Neck Cancer Centre. The Simpson Lab Research Program is focused directly on the translation of research findings into new cancer therapies and has generated a novel method for antibody-mediated cancer therapy and associated companion diagnostic methods which are covered by three international patent applications and published in Cell (March 2020) and Cell Press STAR Protocols (Aug 2020). Fiona was the lead scientific investigator on a Phase I proof of concept study of the novel therapy in head and neck cancer (HREC/15/QPAH/48) and the Lead scientific Investigator on Phase IB September dose escalation trail (CESTEM-1), now completed.
Monday 28 September 2020
This event will be hosted via the Zoom platform. Zoom is accessible on your computer, tablet or phone via the Zoom app. If you have any issues with this platform on your device, please visit the Zoom support site. Alternatively please contact your IT administrator.